Common Contracts
1 similar Managed Access Agreement contracts
Nusinersen Managed Access Agreement: interim arrangements for ambulation stopping criteria as explained on NICE website 29.10.2020Managed Access Agreement • October 28th, 2020
These interim arrangements apply only to Type 3 paediatric Spinal Muscular Atrophy (SMA) patients who lost ambulation in the 12 months prior to 28th July 2019 and who have been initiated on nusinersen.
